Explore the complex world of generic drug patent litigation, from Hatch-Waxman mechanics to Orange Book strategies and the financial impact of settlements on healthcare costs.
Read More
Generic drugs approved by the FDA often face multi-year delays due to patent lawsuits. Between 2023 and 2025, patent thickets, the 30-month stay, and litigation costs blocked affordable access for millions of patients.
Read More